anagrelide
Showing 1 - 6 of 6
Essential Thrombocythemia Trial (Bomedemstat, Anagrelide, Busulfan)
Not yet recruiting
- Essential Thrombocythemia
- Bomedemstat
- +4 more
- (no location specified)
Oct 6, 2023
MPN (Myeloproliferative Tumors) Trial in United States (Ruxolitinib, Anagrelide, Placebo)
Terminated
- MPN (Myeloproliferative Neoplasms)
- Ruxolitinib
- +2 more
-
Phoenix, Arizona
- +25 more
Oct 21, 2021
Thrombocythemia, Hemorrhagic Trial in Worldwide (Anagrelide, Hydroxyurea)
Completed
- Thrombocythemia, Hemorrhagic
- Anagrelide
- Hydroxyurea
-
Pleven, Bulgaria
- +14 more
May 13, 2021
Essential Thrombocythemia Trial in Tours (Anagrelide, Ruxolitinib (JAKAVI®), IFNa/ PegIFNa)
Terminated
- Essential Thrombocythemia
- Anagrelide
- +2 more
-
Tours, FranceFILO
Jun 28, 2021
Essential Thrombocythemia Trial in Worldwide (Ropeginterferon alfa-2b, Anagrelide)
Recruiting
- Essential Thrombocythemia
- Ropeginterferon alfa-2b
- Anagrelide
-
Phoenix, Arizona
- +60 more
Dec 30, 2021
Essential Thrombocythaemia Trial in Worldwide (Anagrelide, Hydroxyurea)
Completed
- Essential Thrombocythaemia
- Anagrelide
- Hydroxyurea
-
Innsbruck, Tirol, Austria
- +23 more
Oct 5, 2010